TOBETA-XL metoprolol succinate 95 mg modified release tablet bottle Australia - Inggris - Department of Health (Therapeutic Goods Administration)

tobeta-xl metoprolol succinate 95 mg modified release tablet bottle

pharmacor pty ltd - metoprolol succinate, quantity: 95 mg - tablet, modified release - excipient ingredients: methacrylic acid copolymer; triethyl citrate; povidone; silicified microcrystalline cellulose; microcrystalline cellulose; silicon dioxide; ethylcellulose; purified talc; macrogol 6000; croscarmellose sodium; sodium stearylfumarate; titanium dioxide; hypromellose; peg-150 distearate; lauromacrogol 400 - stable, chronic heart failure as an adjunct to other heart failure therapy.

TOPRELOC-XL metoprolol succinate 95 mg modified release tablet bottle Australia - Inggris - Department of Health (Therapeutic Goods Administration)

topreloc-xl metoprolol succinate 95 mg modified release tablet bottle

pharmacor pty ltd - metoprolol succinate, quantity: 95 mg - tablet, modified release - excipient ingredients: silicified microcrystalline cellulose; triethyl citrate; purified talc; croscarmellose sodium; silicon dioxide; ethylcellulose; macrogol 6000; povidone; sodium stearylfumarate; methacrylic acid copolymer; microcrystalline cellulose; titanium dioxide; hypromellose; peg-150 distearate; lauromacrogol 400 - stable, chronic heart failure as an adjunct to other heart failure therapy.

TOPRELOC-XL  metoprolol succinate 23.75 mg modified release tablet bottle Australia - Inggris - Department of Health (Therapeutic Goods Administration)

topreloc-xl metoprolol succinate 23.75 mg modified release tablet bottle

pharmacor pty ltd - metoprolol succinate, quantity: 23.75 mg - tablet, modified release - excipient ingredients: triethyl citrate; macrogol 6000; croscarmellose sodium; povidone; sodium stearylfumarate; purified talc; silicon dioxide; silicified microcrystalline cellulose; methacrylic acid copolymer; ethylcellulose; microcrystalline cellulose; titanium dioxide; hypromellose; peg-150 distearate; lauromacrogol 400 - stable, chronic heart failure as an adjunct to other heart failure therapy.

TOBETA-XL metoprolol succinate 23.75 mg modified release tablet blister pack Australia - Inggris - Department of Health (Therapeutic Goods Administration)

tobeta-xl metoprolol succinate 23.75 mg modified release tablet blister pack

arrotex pharmaceuticals pty ltd - metoprolol succinate, quantity: 23.75 mg - tablet, modified release - excipient ingredients: purified talc; macrogol 6000; microcrystalline cellulose; povidone; silicon dioxide; triethyl citrate; sodium stearylfumarate; croscarmellose sodium; silicified microcrystalline cellulose; methacrylic acid copolymer; ethylcellulose; titanium dioxide; hypromellose; peg-150 distearate; lauromacrogol 400 - stable, chronic heart failure as an adjunct to other heart failure therapy.

TOPRELOC-XL metoprolol succinate 47.5 mg modified release tablet blister pack Australia - Inggris - Department of Health (Therapeutic Goods Administration)

topreloc-xl metoprolol succinate 47.5 mg modified release tablet blister pack

pharmacor pty ltd - metoprolol succinate, quantity: 47.5 mg - tablet, modified release - excipient ingredients: triethyl citrate; croscarmellose sodium; microcrystalline cellulose; ethylcellulose; silicified microcrystalline cellulose; macrogol 6000; silicon dioxide; povidone; purified talc; sodium stearylfumarate; methacrylic acid copolymer; titanium dioxide; hypromellose; peg-150 distearate; lauromacrogol 400 - stable, chronic heart failure as an adjunct to other heart failure therapy.

TOPRELOC-XL metoprolol succinate 190 mg modified release tablet blister pack Australia - Inggris - Department of Health (Therapeutic Goods Administration)

topreloc-xl metoprolol succinate 190 mg modified release tablet blister pack

pharmacor pty ltd - metoprolol succinate, quantity: 190 mg - tablet, modified release - excipient ingredients: microcrystalline cellulose; silicified microcrystalline cellulose; triethyl citrate; macrogol 6000; silicon dioxide; croscarmellose sodium; purified talc; ethylcellulose; povidone; sodium stearylfumarate; methacrylic acid copolymer; titanium dioxide; hypromellose; peg-150 distearate; lauromacrogol 400 - stable, chronic heart failure as an adjunct to other heart failure therapy.

TOBETA-XL metoprolol succinate 95 mg modified release tablet blister pack Australia - Inggris - Department of Health (Therapeutic Goods Administration)

tobeta-xl metoprolol succinate 95 mg modified release tablet blister pack

arrotex pharmaceuticals pty ltd - metoprolol succinate, quantity: 95 mg - tablet, modified release - excipient ingredients: silicified microcrystalline cellulose; purified talc; macrogol 6000; methacrylic acid copolymer; microcrystalline cellulose; povidone; croscarmellose sodium; ethylcellulose; silicon dioxide; triethyl citrate; sodium stearylfumarate; titanium dioxide; hypromellose; peg-150 distearate; lauromacrogol 400 - stable, chronic heart failure as an adjunct to other heart failure therapy.

TOBETA-XL metoprolol succinate 190 mg modified release tablet bottle Australia - Inggris - Department of Health (Therapeutic Goods Administration)

tobeta-xl metoprolol succinate 190 mg modified release tablet bottle

pharmacor pty ltd - metoprolol succinate, quantity: 190 mg - tablet, modified release - excipient ingredients: ethylcellulose; povidone; silicified microcrystalline cellulose; sodium stearylfumarate; methacrylic acid copolymer; triethyl citrate; microcrystalline cellulose; croscarmellose sodium; silicon dioxide; macrogol 6000; purified talc; titanium dioxide; hypromellose; peg-150 distearate; lauromacrogol 400 - stable, chronic heart failure as an adjunct to other heart failure therapy.

Sunsilk Purifying Scalp Care Selandia Baru - Inggris - Medsafe (Medicines Safety Authority)

sunsilk purifying scalp care

unilever australasia division of unilever new zealand limited - pyrithione zinc 0.98%{relative} - shampoo - 1% w/w - active: pyrithione zinc 0.98%{relative} excipient: 1,5-pentanediol carbomer citric acid cocamidopropyl betaine dimethiconol dimeticone ethylene glycol distearate glycerol glydant guar hydroxypropyltrimonium chloride sodium laureth sulfate / sodium c12-13 pareth sulfate lauromacrogol 1150 lauromacrogol 200 macrogols magnesium chloride magnesium nitrate methyl hydroxybenzoate methylchloroisothiazolinone and methylisothiazolinone milk, fat free peg-40 castor oil persea americana poloxamer 407 ppg-12-buteth-16 sodium benzoate sodium chloride sodium hydroxide sodium laureth sulfate sodium polynaphthalenesulfonate triethanolamine dodecylbenzenesulfonate trolamine sulfate water xanthan gum zinc sulfate

HI VETIC- tolnaftate ointment Amerika Serikat - Inggris - NLM (National Library of Medicine)

hi vetic- tolnaftate ointment

sato pharmaceutical co., ltd. - tolnaftate (unii: 06kb629tkv) (tolnaftate - unii:06kb629tkv) - tolnaftate 1 g in 100 g - purpose     antifungal uses ■for effective treatment of most athlete’s foot, jock itch, and ringworm           ■prevents the recurrence of most athlete’s foot with daily use